Chris Bland, co-founder at Disrupt Insight, said: “We are delighted to have Kar Hoo join our senior team to drive forward our ...

The Institute of Development Studies (IDS) announces today that Professor Anuradha Joshi has been appointed as its new ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

Ozak AI ($OZ), a presale token valued at $0.014, is attracting global attention as early adopters report significant gains, stoking speculation about its millio ...

Peter C. Akerley, President, Chief Executive Officer and Director, Erdene Resource Development Corp. ("Erdene" or the "Company") (TSX: ERD), shares the Company's story in an interview with TMX ...

Validated Across Influenza A and Influenza B, Including H3N2 Subclade K and Zoonotic Influenza A Subtypes H5, H7, H9AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or ...

The article describes the roles of New Orleans' City Planning Commission and Board of Zoning Adjustments in shaping the ...

Space mining often sounds like a fast route to endless metals. In practice, the first question is simple: what are small ...

Hutson Companies buys 1,089 acres near Jacksonville International Airport, setting up large-scale residential and commercial ...

Nucleome Therapeutics nominates first preclinical development candidate First-in-class monoclonal antibody agonist programme for inflammation resolution with broad applicability across major chronic ...

Setrusumab is a monoclonal antibody that inhibits sclerostin, a protein that negatively regulates bone development, allowing for new bone formation.

An overview of how specialty laboratories use integrated scientific approaches to deliver high-quality infectious disease ...